Eastman Kodak Co
KODK NYSE Photographic Equipment & Supplies Financials FY2016βFY2025
What Eastman Kodak Co does
No business description yet.
- Legal name
- EASTMAN KODAK CO
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 12, 2026
- Accession Β· CIK
- 0001193125-26-104214
0000031235
Revenue and margins
Eastman Kodak Co had $1.1B of revenue in fiscal 2025, up 2.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $446M in fiscal 2025, 41.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Eastman Kodak Co returned $9.0M to shareholders in fiscal 2025, 2% of free cash flow. The diluted share count fell 5.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Eastman Kodak Co can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $362M | $217M | $255M | $201M | $436M |
| Debt incl. finance leases | $255M | $317M | $458M | $468M | $210M |
| Net debt / EBITDA | β | 33.3x | 6.0x | 12.7x | β7.8x |
| Debt / equity | 0.3x | 0.3x | 0.5x | 0.7x | 0.3x |
| Interest coverage | β1.4x | β0.7x | 0.1x | β0.1x | 0.0x |
| Current ratio | 2.6x | 2.3x | 2.5x | 2.3x | 3.1x |
| Quick ratio | 1.9x | 1.5x | 1.7x | 1.4x | 2.3x |
| Total assets | $2.2B | $2.3B | $2.4B | $2.0B | $1.6B |
| Total liabilities | $1.2B | $1.0B | $1.2B | $1.1B | $904M |
| Shareholders' equity | $781M | $1.0B | $931M | $641M | $614M |
| Net debt (β = net cash) | β$107M | $100M | $203M | $267M | β$226M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 9 | 2 / 9 | 7 / 9 | 3 / 9 | 4 / 9 | 2 / 9 | 5 / 9 | 4 / 9 | 7 / 9 |
| Accruals ratio | 1.7% | 9.2% | 2.9% | 7.1% | β38.0% | 4.2% | 6.4% | 1.6% | 5.0% | β33.6% |
| Altman Z'' | 2.19 | 0.96 | β0.39 | 0.99 | β0.20 | 1.15 | 1.27 | 1.33 | 1.02 | 1.99 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.6B | $1.4B | $1.3B | $1.2B | $1.0B | $1.2B | $1.2B | $1.1B | $1.0B | $1.1B |
| Gross profit | $403M | $211M | $180M | $182M | $135M | $164M | $170M | $210M | $203M | $232M |
| Research and development | $60.0M | $64.0M | $48.0M | $42.0M | $34.0M | $33.0M | $34.0M | $34.0M | $33.0M | $33.0M |
| Operating income | $113M | β$207M | β$118M | β$102M | β$74.0M | β$46.0M | β$26.0M | $4.0M | β$7.0M | $0.0M |
| Interest expense | $60.0M | $8.0M | $9.0M | $16.0M | $12.0M | $33.0M | $40.0M | $52.0M | $59.0M | $62.0M |
| Pretax income | $51.0M | β$26.0M | β$13.0M | β$60.0M | β$376M | $28.0M | $31.0M | $87.0M | $110M | β$112M |
| Income tax | $33.0M | β$120M | β$4.0M | $31.0M | $168M | $4.0M | $5.0M | $12.0M | $8.0M | $16.0M |
| Net income | $15.0M | $94.0M | β$16.0M | $116M | β$541M | $24.0M | $26.0M | $75.0M | $102M | β$128M |
| Net income to common | β | β | β | β | β | $22.0M | $13.0M | $56.0M | $78.0M | β$155M |
| Diluted EPS | $0.28 | $1.76 | β$0.84 | $2.23 | β$9.77 | $0.27 | $0.16 | $0.67 | $0.90 | β$1.78 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.06B | 0.08B | 0.08B | 0.09B | 0.09B | 0.09B |
| Cash flow | ||||||||||
| Cash from operations | β$15.0M | β$67.0M | β$62.0M | $12.0M | β$35.0M | β$47.0M | β$116M | $38.0M | β$7.0M | $480M |
| Capital expenditure | $41.0M | $38.0M | $33.0M | $15.0M | $17.0M | $21.0M | $31.0M | $32.0M | $56.0M | $34.0M |
| Free cash flow | β$56.0M | β$105M | β$95.0M | β$3.0M | β$52.0M | β$68.0M | β$147M | $6.0M | β$63.0M | $446M |
| Depreciation and amortization | $105M | $80.0M | $73.0M | $55.0M | $37.0M | $31.0M | $29.0M | $30.0M | $28.0M | $29.0M |
| Stock-based compensation | $8.0M | $9.0M | $6.0M | $7.0M | $15.0M | $7.0M | $5.0M | $7.0M | $6.0M | $5.0M |
| Share buybacks | $3.0M | $1.0M | β | β | $0.0M | $1.0M | $1.0M | $0.0M | $1.0M | $7.0M |
| Dividends paid | β | $10.0M | $8.0M | $3.0M | $22.0M | $7.0M | $4.0M | $4.0M | $4.0M | $2.0M |
| Dividends and buybacks | $3.0M | $11.0M | $8.0M | $3.0M | $22.0M | $8.0M | $5.0M | $4.0M | $5.0M | $9.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $434M | $343M | $233M | $233M | $196M | $362M | $217M | $255M | $201M | $436M |
| Total debt | $411M | $403M | $797M | $111M | $19.0M | $254M | $317M | $458M | $467M | $209M |
| Finance lease liabilities | β | β | β | $5.0M | $4.0M | $1.0M | β | β | $1.0M | $1.0M |
| Current assets | $1.0B | $958M | $910M | $706M | $627M | $807M | $681M | $712M | $595M | $841M |
| Current liabilities | $417M | $419M | $778M | $368M | $296M | $309M | $293M | $283M | $261M | $268M |
| Inventory | $271M | $246M | $231M | $215M | $206M | $219M | $237M | $217M | $219M | $218M |
| Property and equipment, net | $342M | $294M | $216M | $181M | $152M | $140M | $154M | $169M | $189M | $191M |
| Goodwill | $68.0M | $12.0M | $12.0M | $12.0M | $12.0M | $12.0M | $12.0M | $12.0M | $12.0M | $12.0M |
| Intangible assets | $121M | $84.0M | $58.0M | $47.0M | $39.0M | $34.0M | $28.0M | $24.0M | $20.0M | $17.0M |
| Total assets | $1.8B | $1.7B | $1.5B | $1.4B | $1.2B | $2.2B | $2.3B | $2.4B | $2.0B | $1.6B |
| Total liabilities | $1.7B | $1.5B | $1.3B | $1.1B | $980M | $1.2B | $1.0B | $1.2B | $1.1B | $904M |
| Shareholders' equity | β$73.0M | $57.0M | β$3.0M | $99.0M | $77.0M | $781M | $1.0B | $931M | $641M | $614M |
| Margins | ||||||||||
| Gross margin | 24.5% | 15.2% | 13.6% | 14.7% | 13.1% | 14.3% | 14.1% | 18.8% | 19.5% | 21.7% |
| Operating margin | 6.9% | β14.9% | β8.9% | β8.2% | β7.2% | β4.0% | β2.2% | 0.4% | β0.7% | 0.0% |
| EBITDA margin | 13.3% | β9.2% | β3.4% | β3.8% | β3.6% | β1.3% | 0.2% | 3.0% | 2.0% | 2.7% |
| Net margin | 0.9% | 6.8% | β1.2% | 9.3% | β52.6% | 2.1% | 2.2% | 6.7% | 9.8% | β12.0% |
| FCF margin | β3.4% | β7.6% | β7.2% | β0.2% | β5.1% | β5.9% | β12.2% | 0.5% | β6.0% | 41.7% |
| Returns | ||||||||||
| Return on capital | β | β139.8% | β16.6% | β | β | β5.9% | β1.9% | 0.3% | β0.7% | 0.0% |
| Return on capital employed | 8.3% | β16.1% | β16.1% | β9.7% | β7.8% | β2.5% | β1.3% | 0.2% | β0.4% | 0.0% |
| Return on equity | β | β | β59.3% | 241.7% | β614.8% | 5.6% | 2.9% | 7.6% | 13.0% | β20.4% |
| Return on assets | 0.8% | 5.4% | β1.0% | 7.9% | β40.6% | 1.4% | 1.2% | 3.2% | 4.7% | β7.1% |
| Return on tangible equity | β | β | β | 290.0% | β2,080.8% | 3.0% | 1.3% | 6.3% | 12.8% | β26.5% |
| Growth | ||||||||||
| Revenue growth | β | β15.6% | β4.8% | β5.9% | β17.1% | 11.8% | 4.8% | β7.3% | β6.6% | 2.5% |
| Net income growth | β | 526.7% | β117.0% | β | β566.4% | β | 8.3% | 188.5% | 36.0% | β225.5% |
| EPS growth | β | 528.6% | β147.7% | β | β538.1% | β | β40.7% | 318.8% | 34.3% | β297.8% |
| FCF growth | β | β | β | β | β | β | β | β | β1,150.0% | β |
| Share count change | β | 0.5% | 0.0% | 0.7% | 33.5% | 40.2% | 0.1% | 12.3% | 2.0% | β5.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.1x | β | β | β | β | β | 33.3x | 6.0x | 12.7x | β7.8x |
| Debt / equity | β | 7.1x | β | 1.1x | 0.2x | 0.3x | 0.3x | 0.5x | 0.7x | 0.3x |
| Interest coverage | 1.9x | β25.9x | β13.1x | β6.4x | β6.2x | β1.4x | β0.7x | 0.1x | β0.1x | 0.0x |
| Current ratio | 2.5x | 2.3x | 1.2x | 1.9x | 2.1x | 2.6x | 2.3x | 2.5x | 2.3x | 3.1x |
| Quick ratio | 1.8x | 1.7x | 0.9x | 1.3x | 1.4x | 1.9x | 1.5x | 1.7x | 1.4x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.5% | 2.7% | 2.5% | 1.2% | 1.7% | 1.8% | 2.6% | 2.9% | 5.4% | 3.2% |
| Stock comp / revenue | 0.5% | 0.6% | 0.5% | 0.6% | 1.5% | 0.6% | 0.4% | 0.6% | 0.6% | 0.5% |
| Payouts / FCF | β | β | β | β | β | β | β | 66.7% | β | 2.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 2.0 | 2.0 | 7.0 | 3.0 | 4.0 | 2.0 | 5.0 | 4.0 | 7.0 |
| Altman Z'' | 2.2 | 1.0 | β0.4 | 1.0 | β0.2 | 1.2 | 1.3 | 1.3 | 1.0 | 2.0 |
| Accruals ratio | 1.7% | 9.2% | 2.9% | 7.1% | β38.0% | 4.2% | 6.4% | 1.6% | 5.0% | β33.6% |
Source: SEC EDGAR XBRL filings (CIK 0000031235). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.